Microvision, Inc. (NASDAQ:MVIS) is sure making steps forward, as its recent $4M order from Pioneer to supply components related to its HD PicoP laser-based display technology, brought its stock back up. Microvision’s technology will be sued by Pioneer in car navigation systems, and the company will also collect royalties from Pioneer, according to the terms of an April agreement. Microvision shares rose 38.74% to $2.65, and they have traded in a 52-week range of $1.11 to $12.40.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA): Shares of Synta Pharmaceuticals rose after Jefferies kept the firm at a Buy rating with a $7 price target. Jefferies said it believes the Phase 2b lung cancer trial data could lead to a rise in the price of Synta Pharmaceuticals shares and said it would be a buyer of the stock before the June data release. Synta Pharmaceuticals shares were up 15.63% and closed at $4.81. They have traded in a 52-week range of $3.02 to $5.74.
Ciena Corporation (NASDAQ:CIEN) reported positive Q2 results that beat consensus estimates, and Argus reiterated a Buy rating on shares with a $21 price target. Argus attributed the decline in gross margins to a shift in product mix that the firm hopes to improve in the latter half of the year. Ciena shares rose 14.06% to $13.55, and they have traded in a 52-week range of $9.89 to $26.20.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.